META-ANALYSIS ON THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS COMPARED WITH VITAMIN K ANTAGONISTS IN PATIENTS UNDERGOING CARDIOVERSION FOR ATRIAL FIBRILLATION

META-ANALYSIS ON THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS COMPARED WITH VITAMIN K ANTAGONISTS IN PATIENTS UNDERGOING CARDIOVERSION FOR ATRIAL FIBRILLATION

Background: Novel oral anticoagulants (NOACs) have been found to be safe and effective for the prevention of systemic thromboembolim (STE) in non-valvular atrial fibrillation (AF) but their experience in patients undergoing cardioversion (CV) is limited.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.447-447
Hauptverfasser: Turagam, Mohit, Velagapudi, Poonam, Vuddanda, Venkat, Lavu, Madhav, Jazayeri, Mohammad-Ali, Parikh, Valay, Tarun, Tushar, Atkins, Donita, Aggarwal, Kul, Bommana, Sudharani, Di Biase, Luigi, Natale, Andrea, Reddy, Madhu
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiac arrhythmia
Cardiology
Cardiovascular
Health risk assessment
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Novel oral anticoagulants (NOACs) have been found to be safe and effective for the prevention of systemic thromboembolim (STE) in non-valvular atrial fibrillation (AF) but their experience in patients undergoing cardioversion (CV) is limited.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)33836-6